SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

29 Apr 2022 Evaluate
The revenue zoomed 7.22% to Rs. 84.18 millions for the quarter ended March 2022 as compared to Rs. 78.51 millions during the corresponding quarter last year.The Total revenue for the quarter ended March 2022 of  Rs. 141.20  millions  grew by 1096.61% from Rs. 11.80 millions.Operating profit for the quarter ended March 2022 rose to 37.21 millions as compared to 33.76 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 84.18 78.51 7.22 365.65 224.45 62.91 365.65 224.45 62.91
Other Income 4.92 3.39 45.13 6.29 4.08 54.17 6.29 4.08 54.17
PBIDT 37.21 33.76 10.22 180.90 67.89 166.46 180.90 67.89 166.46
Interest 1.48 4.58 -67.69 12.15 15.48 -21.51 12.15 15.48 -21.51
PBDT 35.73 29.18 22.45 168.75 52.41 221.98 168.75 52.41 221.98
Depreciation 17.28 17.38 -0.58 69.74 64.56 8.02 69.74 64.56 8.02
PBT 18.45 11.80 56.36 99.01 -12.15 -914.90 99.01 -12.15 -914.90
TAX -122.75 0.00 0.00 -122.75 0.00 0.00 -122.75 0.00 0.00
Deferred Tax -122.75 0.00 0.00 -122.75 0.00 0.00 -122.75 0.00 0.00
PAT 141.20 11.80 1096.61 221.76 -12.15 -1925.19 221.76 -12.15 -1925.19
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 44.20 43.00 2.80 49.47 30.25 63.56 49.47 30.25 63.56

Zenotech Laboratorie Share Price

45.50 -1.40 (-2.99%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×